172 related articles for article (PubMed ID: 2583222)
21. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
22. Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes.
See RH; Krystal G; Chow AW
Can J Microbiol; 1992 Sep; 38(9):937-44. PubMed ID: 1281444
[TBL] [Abstract][Full Text] [Related]
23. Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.
Fukushima H; Hirano T; Oka K
Eur J Pharmacol; 2007 Sep; 570(1-3):222-8. PubMed ID: 17610867
[TBL] [Abstract][Full Text] [Related]
24. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen.
Takahashi N; Imanishi K; Nishida H; Uchiyama T
J Immunol; 1995 Dec; 155(11):5213-9. PubMed ID: 7594532
[TBL] [Abstract][Full Text] [Related]
25. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
26. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells.
Imanishi K; Igarashi H; Uchiyama T
J Immunol; 1990 Nov; 145(10):3170-6. PubMed ID: 2230113
[TBL] [Abstract][Full Text] [Related]
27. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
[TBL] [Abstract][Full Text] [Related]
28. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
29. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
[TBL] [Abstract][Full Text] [Related]
30. Post-thymic maturation of migrating human thymic single-positive T cells: thymic CD1a- CD4+ T cells are more susceptible to anergy induction by toxic shock syndrome toxin-1 than cord blood CD4+ T cells.
Imanishi K; Seo K; Kato H; Miyoshi-Akiyama T; Zhang RH; Takanashi Y; Imai Y; Uchiyama T
J Immunol; 1998 Jan; 160(1):112-9. PubMed ID: 9551963
[TBL] [Abstract][Full Text] [Related]
31. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
Kum WW; Hung RW; Cameron SB; Chow AW
J Infect Dis; 2002 Feb; 185(4):555-60. PubMed ID: 11865410
[TBL] [Abstract][Full Text] [Related]
32. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
[TBL] [Abstract][Full Text] [Related]
33. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
Mourad W; Scholl P; Diaz A; Geha R; Chatila T
J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
[TBL] [Abstract][Full Text] [Related]
34. Separation of function between the domains of toxic shock syndrome toxin-1.
Wahlsten JL; Ramakrishnan S
J Immunol; 1998 Jan; 160(2):854-9. PubMed ID: 9551921
[TBL] [Abstract][Full Text] [Related]
35. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
37. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
38. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression.
Mehindate K; al-Daccak R; Damdoumi F; Mourad W
Eur J Immunol; 1996 Sep; 26(9):2075-80. PubMed ID: 8814249
[TBL] [Abstract][Full Text] [Related]
40. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.
Panina-Bordignon P; Fu XT; Lanzavecchia A; Karr RW
J Exp Med; 1992 Dec; 176(6):1779-84. PubMed ID: 1460432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]